Zevin Asset Management LLC Buys 768 Shares of Danaher Co. (NYSE:DHR)

Zevin Asset Management LLC increased its stake in Danaher Co. (NYSE:DHR) by 1.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 67,015 shares of the conglomerate’s stock after purchasing an additional 768 shares during the period. Danaher makes up 3.1% of Zevin Asset Management LLC’s holdings, making the stock its 11th biggest holding. Zevin Asset Management LLC’s holdings in Danaher were worth $9,679,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of DHR. Howe & Rusling Inc. grew its position in Danaher by 116.3% in the third quarter. Howe & Rusling Inc. now owns 186 shares of the conglomerate’s stock valued at $27,000 after acquiring an additional 100 shares during the last quarter. Next Capital Management LLC bought a new position in Danaher in the second quarter valued at about $31,000. Litman Gregory Asset Management LLC bought a new position in Danaher in the second quarter valued at about $33,000. Altshuler Shaham Ltd grew its position in Danaher by 59.3% in the second quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 89 shares during the last quarter. Finally, Pinnacle Bank grew its position in Danaher by 52.3% in the third quarter. Pinnacle Bank now owns 262 shares of the conglomerate’s stock valued at $38,000 after acquiring an additional 90 shares during the last quarter. Institutional investors own 78.30% of the company’s stock.

Shares of DHR stock traded up $0.73 during mid-day trading on Friday, reaching $135.23. 1,633,369 shares of the stock traded hands, compared to its average volume of 2,487,994. The stock’s fifty day simple moving average is $139.07 and its two-hundred day simple moving average is $138.28. Danaher Co. has a 1-year low of $94.59 and a 1-year high of $147.33. The company has a market cap of $95.87 billion, a price-to-earnings ratio of 29.92, a price-to-earnings-growth ratio of 2.24 and a beta of 0.92. The company has a quick ratio of 3.09, a current ratio of 3.43 and a debt-to-equity ratio of 0.52.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Thursday, October 24th. The conglomerate reported $1.16 EPS for the quarter, topping the Zacks’ consensus estimate of $1.15 by $0.01. The company had revenue of $5.04 billion for the quarter, compared to analyst estimates of $5.02 billion. Danaher had a return on equity of 11.42% and a net margin of 12.13%. The firm’s quarterly revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.10 earnings per share. On average, equities research analysts anticipate that Danaher Co. will post 4.76 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.50%. The ex-dividend date was Thursday, September 26th. Danaher’s dividend payout ratio is currently 15.04%.

A number of research analysts have issued reports on the company. Robert W. Baird lifted their target price on Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Wolfe Research set a $154.00 price target on Danaher and gave the company a “buy” rating in a research note on Friday, October 25th. Argus lifted their price target on Danaher to $165.00 and gave the company a “buy” rating in a research note on Tuesday, July 23rd. Piper Jaffray Companies lifted their price target on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a research note on Thursday, July 18th. Finally, Credit Suisse Group reissued an “outperform” rating and set a $151.00 price target on shares of Danaher in a research note on Monday, October 14th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Danaher presently has an average rating of “Buy” and a consensus price target of $145.86.

In related news, Chairman Mitchell P. Rales acquired 2,500 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were bought at an average cost of $139.52 per share, with a total value of $348,800.00. Following the completion of the purchase, the chairman now directly owns 3,030,453 shares in the company, valued at $422,808,802.56. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 11.40% of the stock is owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Article: What is the Coverage Ratio?

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply